In the BioHarmony Drug Report Database

"Preview" Icon

Telaprevir

Incivek (telaprevir) is a protein pharmaceutical. Telaprevir was first approved as Incivek on 2011-05-23. It is used to treat chronic hepatitis c and hepatitis c in the USA. It is known to target lysosomal protective protein and chymotrypsin-like elastase family member 1. Incivo’s patents are valid until 2028-05-30 (FDA).

 

Trade Name

 

Incivek
 

Common Name

 

telaprevir
 

ChEMBL ID

 

CHEMBL231813
 

Indication

 

chronic hepatitis c, hepatitis c
 

Drug Class

 

Antivirals: serine protease inhibitors

Image (chem structure or protein)

Telaprevir structure rendering